Evidence map›Paper›PMID 33043280›Full record

ArticleJournal of the American College of Clinical Pharmacy : JACCP2020

Global contributions of pharmacists during the COVID-19 pandemic.

Debra A Goff, Diane Ashiru-Oredope, Kelly A Cairns, Khalid Eljaaly, Timothy P Gauthier, Bradley J Langford, Sara Fouad Mahmoud, Angeliki P Messina, Ubaka Chukwuemeka Michael, Thérèse Saad and 1 more

Abstract read
In one paragraph

Article in Journal of the American College of Clinical Pharmacy : JACCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Formal leadership perceptions about the autonomy of Pharmacy: a SWOT analysis.Exploratory research in clinical and social pharmacy · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Debra A GoffThe Ohio State University Wexner Medical Center The Ohio State University College of Pharmacy Columbus Ohio USA.ORCID https://orcid.org/0000-0001-7686-0670
Diane Ashiru-OredopeNational Infection Service Public Health England London UK.
Kelly A CairnsAlfred Health Melbourne Victoria Australia.
Khalid EljaalyFaculty of Pharmacy King Abdulaziz University Jeddah Saudi Arabia.
Timothy P GauthierBaptist Health South Florida Miami Florida USA.
Bradley J LangfordPublic Health Ontario Toronto Ontario Canada.ORCID https://orcid.org/0000-0001-5467-6776
Sara Fouad MahmoudHamad Medical Corporation Doha Qatar.
Angeliki P MessinaDivision of Pharmacy Netcare Hospitals Ltd Johannesburg South Africa.
Ubaka Chukwuemeka MichaelDepartment of Clinical Pharmacy and Pharmacy Management University of Nigeria Nsukka Enugu Nigeria.
Thérèse SaadDepartment of Pharmacy American University of Beirut Medical Center Beirut Lebanon.
Natalie SchellackSchool of Pharmacy, Faculty of Health Sciences Sefako Makgatho Health Sciences University Pretoria South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Throughout the SARS-CoV-2 (COVID-19) global pandemic, pharmacists were rarely mentioned as essential frontline health care providers by the news media, the public, or politicians. Around the world, pharmacists are working on the frontlines of health care every day providing essential health care services during the pandemic. Pharmacists are medication experts providing patient care in a variety of settings including hospitals, clinics, community pharmacies, long-term care, physician offices, and national and public health. In this paper, we describe how pharmacists from high and low-middle income countries contributed to essential patient care and well-being of the public during the COVID-19 pandemic. While the news media, the public, and politicians often overlooked pharmacists as essential frontline health care providers, we hope that this list of contributions by pharmacists from nine countries in this article can help to change this perspective.

Indexed as

antibiotic stewardshipcoronavirusglobal healthpandemicpharmacistspharmacy

Identifiers

PMID33043280
PMCPMC7537072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.